Showing results (411-420 of 11,968) with videos related to
Sort By:
Pageof 1,197
Epilepsia|November 18, 2020
Precision Medicine: Academic dreaming or clinical reality?Colin B Josephson, Samuel WiebeEpilepsia|October 22, 2020
Polygenic risk heterogeneity among focal epilepsiesMarie Gramm, Costin Leu, Eduardo Pérez-Palma, et al.Epilepsia|October 24, 2020
Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30-year longitudinal cohort studyBshra Ali A Alsfouk, Haris Hakeem, Zhibin Chen, et al.Epilepsia|October 24, 2020
Anterior temporal encephaloceles: Elusive, important, and rewarding to treatGabrielle T Tse, Aviva S Frydman, Marie F O'Shea, et al.Epilepsia|October 24, 2020
Atipamezole, a specific α2A antagonist, suppresses spike-and-wave discharges and alters Ca2⁺ /calmodulin-dependent protein kinase II in the thalamus of genetic absence epilepsy ratsMelis Yavuz, Banu Aydın, Nihan Çarçak, et al.Epilepsia|October 24, 2020
Generalized, focal, and combined epilepsies in families: New evidence for distinct genetic factorsColin A Ellis, Ruth Ottman, Michael P Epstein, et al.Epilepsia|November 14, 2020
Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in KoreaSoo Jie Chung, Kyung-Min Ahn, Ji Hyun Oh, et al.Epilepsia|November 14, 2020
Development of a novel outcome prediction score (PEDSS) for pediatric convulsive status epilepticus: A longitudinal observational studyRicha Tiwari, Biswaroop Chakrabarty, Sheffali Gulati, et al.Epilepsia|November 14, 2020
Risk for infantile spasms after acute symptomatic neonatal seizuresHannah C Glass, Zachary M Grinspan, Yi Li, et al.Epilepsia|November 9, 2020
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical developmentMeir Bialer, Svein I Johannessen, Matthias J Koepp, et al.Pageof 1,197